Category: Mpox
-
WHO clears Bavarian Nordic’s vaccine as first mpox shot By Reuters
•
By Jennifer Rigby and Manas Mishra The World Health Organization said on Friday it had approved Bavarian Nordic’s Mbox vaccine, the first of its kind approved by the agency to contain the spread of the disease in hard-hit African countries. The approval, known as prequalification, comes as a new variant…
-
UNICEF issues emergency tender to secure mpox vaccines (OTCQX:RHHBY)
•
kontekbrothers UNICEF has issued an emergency tender for the purchase of mpox vaccines for the most affected countries in collaboration with the Africa Centers for Disease Control and Prevention, Gavi, the Vaccine Alliance, the World Health Organization, the Pan American Health Organization and other partners. In a joint statement, the…
-
Emergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpox (NYSE:EBS)
•
Emerging Bio-Solutions (New York: EBS) stocks jumped 23% pre-market Friday The U.S. Food and Drug Administration (FDA) has approved expanded use of the company’s ACAM2000 smallpox vaccine to include people at risk of smallpox infection. Earlier this month, the World Health Organization announced The outbreak of monkeypox, formerly known as…
-
Emergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpox (NYSE:EBS)
•
Emerging Bio-Solutions (New York: EBS) stocks jumped 23% pre-market Friday The U.S. Food and Drug Administration (FDA) has approved expanded use of the company’s ACAM2000 smallpox vaccine to include people at risk of smallpox infection. Earlier this month, the World Health Organization announced The outbreak of monkeypox, formerly known as…
-
Why mpox vaccines are only just arriving in Africa after two years By Reuters
•
(This story was resubmitted from August 24 to correct the name in the credit report to Jaafar Al-Qatantani.) By Jennifer Rigby LONDON (Reuters) – The first 10,000 doses of the MBOX vaccine are finally due to arrive next week in Africa, where a dangerous new strain of the virus that…
-
EF Hutton maintains stock target on GeoVax amid Mpox outbreak By Investing.com
•
On Monday, EF Hutton reiterated its buy rating on shares of GeoVax Labs Inc. (NASDAQ:NASDAQ:) with a hold price target of $18.00. The company’s endorsement comes as GeoVax is actively developing the Modified Vaccinia Ankara (MVA) vaccine to combat the outbreak of smallpox virus type 1 in the Democratic Republic…